|
1
|
Xu QM, Jia D, Gao HW, Zhang MM, He WJ, Pan
S, Liu YL, Li XR, Cui JH and Yang SL: In vitro and in vivo
protective effects of gingenosides on acute renal injury induced by
cantharidin. J Functional Foods. 5:2012–2018. 2013.
|
|
2
|
Chen XJ, Zhang XJ, Shui YM, Wan JB and Gao
JL: Anticancer activities of protopanaxadiol- and
protopanaxatriol-type ginsenosides and their metabolites. Evid
Based Complement Alternat Med. 2016(5738694)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhang G, Liu A, Zhou Y, San X, Jin T and
Jin Y: Panax ginseng ginsenoside-Rg2 protects memory
impairment via anti-apoptosis in a rat model with vascular
dementia. J Ethnopharmacol. 115:441–448. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fan Y, Wang N, Rocchi A, Zhang W, Vassar
R, Zhou Y and He C: Identification of natural products with
neuronal and metabolic benefits through autophagy induction.
Autophagy. 13:41–56. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chung Y, Jeong S, Choi HS, Ro S, Lee JS
and Park JK: Upregulation of autophagy by Ginsenoside Rg2 in MCF-7
cells. Anim Cells Syst (Seoul). 22:382–389. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fu W, Sui D, Yu X, Gou D, Zhou Y and Xu H:
Protective effects of ginsenoside Rg2 against
H2O2-induced injury and apoptosis in H9c2
cells. Int J Clin Exp Med. 8:19938–19947. 2015.PubMed/NCBI
|
|
7
|
Gershon N, Berchenko Y, Hall PS and
Goldstein DA: Cost effectiveness and affordability of trastuzumab
in sub-Saharan Africa for early stage. Cost Eff Resour Alloc.
17(5)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Slamon D, Eiermann W, Robert N, Pienkowski
T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, et
al: Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J
Med. 365:1273–1283. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mazzotta M, Krasniqi E, Barchiesi G,
Pizzuti L, Tomao F, Barba M and Vici P: Long-term safety and
real-world effectiveness of trastuzumab in breast cancer. J Clin
Med. 8(254)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sato A, Yoshihisa A, Miyata-Tatsumi M,
Oikawa M, Kobayashi A, Ishida T, Ohtake T and Takeishi Y: Valvular
heart disease as a possible predictor of trastuzumab-induced
cardiotoxicity in patients with breast cancer. Mol Clin Oncol.
10:37–42. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Biederbick A, Kern HF and Elsässer HP:
Monodansylcadaverine (MDC) is a specific in vivo marker for
autophagic vacuoles. Eur J Cell Biol. 66:3–14. 1995.PubMed/NCBI
|
|
12
|
Jeong SJ, Han SH, Kim DY, Lee JC, Kim HS,
Kim BH, Lee JS, Hwang EH and Park JK: Effects of mRg2, a mixture of
ginsenosides containing 60% Rg2, on the ultraviolet B-induced DNA
repair synthesis and apoptosis in NIH3T3 cells. Int J Toxicol.
26:151–158. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ye J, Yao JP, Wang X, Zheng M, Li P, He C,
Wan JB, Yao X and Su H: Neuroprotective effects of ginsenosides on
neural progenitor cells against oxidative injury. Mol Med Rep.
13:3083–3091. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chung YH, Jeong SA, Choi HS, Ro S, Lee JS
and Park JK: Protective effects of ginsenoside Rg2 and astaxanthin
mixture against UVB-induced DNA damage. Anim Cells Syst (Seoul).
22:400–406. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kang HJ, Huang YH, Lim HW, Shin D, Jang K,
Lee Y, Kim K and Lim CJ: Stereospecificity of ginsenoside Rg2
epimers in the protective response against UV-B radiation-induced
oxidative stress in human epidermal keratinocytes. J Photochem
Photobiol B. 165:232–239. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang CZ, Aung HH, Zhang B, Sun S, Li XL,
He H, Xie JT, He TC, Du W and Yuan CS: Chemopreventive effects of
heat-processed Panax quinquefolius root on human breast cancer
cells. Anticancer Res. 28:2545–2551. 2008.PubMed/NCBI
|
|
17
|
Mondaca-Ruff D, Riquelme JA, Quiroga C,
Norambuena-Soto I, Sanhueza-Olivares F, Villar-Fincheira P,
Hernández-Díaz T, Cancino-Arenas N, San Martin A, García L, et al:
Angiotensin II-regulated autophagy is required for vascular smooth
muscle cell hypertrophy. Front Pharmacol. 9(1553)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gatica D, Chiong M, Lavandero S and
Klionsky DJ: Molecular mechanisms of autophagy in the
cardiovascular system. Circ Res. 116:456–467. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sukawa Y, Yamamoto H, Nosho K, Ito M,
Igarashi H, Naito T, Mitsuhashi K, Matsunaga Y, Takahashi T, Mikami
M, et al: HER2 expression and PI3K-Akt pathway alterations in
gastric cancer. Digestion. 89:12–17. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yang Y, Ren F, Tian Z, Song W, Cheng B and
Feng Z: Osthole synergizes with HER2 inhibitor, trastuzumab in
HER2-overexpressed N87 Gastric cancer by inducing apoptosis and
inhibition of AKT-MAPK pathway. Front Pharmacol.
9(1392)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Han S, Meng Y, Tong Q, Li G, Zhang X, Chen
Y, Hu S, Zheng L, Tan W, Li H, et al: The ErbB2-targeting antibody
trastuzumab and the small-molecule SRC inhibitor saracatinib
synergistically inhibit ErbB2-overexpressing gastric cancer. MAbs.
6:403–408. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yu JS and Cui W: Proliferation, survival
and metabolism: The role of PI3K/AKT/mTOR signalling in
pluripotency and cell fate determination. Development.
143:3050–3060. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hu P, Zhou H, Lu M, Dou L, Bo G, Wu J and
Huang S: Autophagy plays a protective role in advanced glycation
end product-induced apoptosis in cardiomyocytes. Cell Physiol
Biochem. 37:697–706. 2015.PubMed/NCBI View Article : Google Scholar
|
